The Combination Empagliflozin/Metformin Attenuates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Diet-Induced Experimental Rat Model.

Empagliflozin/Metformin 聯合治療減緩飲食誘發大鼠模型中代謝功能障礙相關脂肪性肝病的進展